A Novel Formulation Strategy to Deliver Combined DNA and VLP Based HPV Vaccine
Human papillomaviruses (HPV) are small, double-stranded DNA viruses that cause cervical cancer, the second most lethal cancer among women in the world. Currently, two vaccines are on the market for preventing HPV-caused cervical cancers and warts. Both are virus-like particle (VLP)-based vaccines. H...
Main Authors: | Mohammad Nasir Uddin, Brittany Henry, Kewan D Carter, Monzurul a Roni, Samir S Kouzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30768 |
Similar Items
-
Overview and Future Potential of Fast Dissolving Buccal Films as Drug Delivery System for Vaccines
by: Mohammad Nasir Uddin, et al.
Published: (2019-08-01) -
Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System
by: Mohammad Nasir Uddin, et al.
Published: (2015-06-01) -
RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
by: Bettina Huber, et al.
Published: (2021-03-01) -
A DNA inducing VLP vaccine designed for HIV and tested in mice.
by: Alexandre Calazans, et al.
Published: (2017-01-01) -
Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
by: Bettina Huber, et al.
Published: (2017-01-01)